NYSE:MCK
McKesson Corporation Stock News
$559.91
+4.79 (+0.86%)
At Close: May 10, 2024
McKesson (MCK) Set to Sell Canadian Rexall Pharmacy Group
11:46am, Friday, 19'th Jan 2024
McKesson (MCK) is seeking buyers for the Canadian Rexall Pharmacy Group. The business is currently amid its second round of offers, with no set deadline for submissions.
Here's Why You Should Add McKesson (MCK) to Your Portfolio Now
07:31am, Wednesday, 17'th Jan 2024
McKesson (MCK) continues to benefit from strategic partnerships and strength in the Distribution Solutions segment.
Charts turn bullish on health-care stocks as sector takes early lead in 2024
11:29am, Tuesday, 16'th Jan 2024
Chart-watchers are growing increasingly bullish on health-care stocks now that they have become the best-performing sector of the S&P 500 so far in 2024, according to Dow Jones Market Data. Analysts h
US drug retailer McKesson seeks buyers for Canada's Rexall Pharmacy -source
01:58pm, Friday, 12'th Jan 2024
McKesson Corp is planning to sell Canadian drugstore chain Rexall Pharmacy Group, a source familiar with the process told Reuters on Friday, seven years after the U.S. drug distributor bought the busi
Here's Why McKesson (MCK) is a Strong Value Stock
11:20am, Thursday, 11'th Jan 2024
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
McKesson (MCK) Hits 52-Week High: What's Driving the Stock?
12:02pm, Thursday, 04'th Jan 2024
Investors are optimistic about McKesson's (MCK) strength in its Biologics business.
McKesson Corporation Announces Third Quarter Fiscal 2024 Earnings Release Date and Participation in January Conference
04:10pm, Wednesday, 27'th Dec 2023
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) will release its third quarter fiscal 2024 financial results after market close on Wednesday, February 7, 2024. The company will host a
Silver Economy Successes: 3 Stocks Benefitting From an Aging Population
02:37pm, Wednesday, 27'th Dec 2023
Finding investment opportunities in tune with today's demographic trends can be challenging, but aging population stocks may be the solution. This market is booming in a world with an aging population
McKesson (MCK) Announces Availability of PNH's FDA-Approved Drug
12:01pm, Tuesday, 26'th Dec 2023
The availability of the FDA-approved drug via McKesson's (MCK) independent specialty pharmacy is expected to give patients more treatment options for PNH.
Here's Why You Should Retain McKesson (MCK) Stock for Now
08:17am, Wednesday, 13'th Dec 2023
McKesson (MCK) continues to benefit from strategic partnerships and strength in the Distribution Solutions segment.
McKesson (MCK) Announces Availability of FDA-Approved Drug
12:02pm, Monday, 11'th Dec 2023
The availability of the FDA-approved drug via McKesson's (MCK) independent specialty pharmacy is expected to give patients more treatment options for desmoid tumors.
McKesson (MCK) Announces Availability of FDA-Cleared Drug
10:34am, Monday, 04'th Dec 2023
The availability of the FDA-approved drug via McKesson's (MCK) independent specialty pharmacy is expected to give patients more treatment options for breast cancer.
This 1 Surprising New Tailwind Is Lifting These 2 Evergreen Stocks
10:23am, Monday, 04'th Dec 2023
Medical distributors are seeing increased demand for certain medicines. Drugs for weight loss made by Novo Nordisk and Eli Lilly are what's driving growth.
McKesson (MCK) Announces Availability of FDA-Cleared mCRC Drug
12:49pm, Friday, 17'th Nov 2023
The availability of the FDA-approved drug via McKesson's (MCK) independent specialty pharmacy is expected to give patients more treatment options for mCRC.
3 Biotech Stocks You'll Regret Not Buying Soon: November 2023
04:17pm, Tuesday, 14'th Nov 2023
Biotechnology is a booming industry recently focused on synthetic biology, biomanufacturing and gene editing. Biotech is seen as the key to the future, as it has the potential to cure diseases and sav
